Andrianopoulos, I.; Kazakos, N.; Lagos, N.; Maniatopoulou, T.; Papathanasiou, A.; Papathanakos, G.; Koulenti, D.; Toli, E.; Gartzonika, K.; Koulouras, V.
Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics 2024, 13, 169.
https://doi.org/10.3390/antibiotics13020169
AMA Style
Andrianopoulos I, Kazakos N, Lagos N, Maniatopoulou T, Papathanasiou A, Papathanakos G, Koulenti D, Toli E, Gartzonika K, Koulouras V.
Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics. 2024; 13(2):169.
https://doi.org/10.3390/antibiotics13020169
Chicago/Turabian Style
Andrianopoulos, Ioannis, Nikolaos Kazakos, Nikolaos Lagos, Theodora Maniatopoulou, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Eleni Toli, Konstantina Gartzonika, and Vasilios Koulouras.
2024. "Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes" Antibiotics 13, no. 2: 169.
https://doi.org/10.3390/antibiotics13020169
APA Style
Andrianopoulos, I., Kazakos, N., Lagos, N., Maniatopoulou, T., Papathanasiou, A., Papathanakos, G., Koulenti, D., Toli, E., Gartzonika, K., & Koulouras, V.
(2024). Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics, 13(2), 169.
https://doi.org/10.3390/antibiotics13020169
